冠動脈ステント市場規模、シェア、成長分析、タイプ別、デリバリー別、材料別、エンドユーザー別、地域別-、2024～2031年産業予測

冠動脈ステントの世界市場規模は2022年に99億米ドルと評価され、2023年の102億2,000万米ドルから2031年には131億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは3.2％で成長する展望です。

世界の冠動脈ステント市場は、心血管疾患の急増、高齢化、低侵襲手術への嗜好の高まりなどを背景に、顕著な成長を遂げています。ライフスタイルの変化や不健康な食生活がこれらの疾患の罹患率上昇の一因となっているため、冠動脈ステントの需要が高まっています。薬剤溶出性ステントや生体吸収性ステントなどの技術革新により、患者の転帰と安全性が向上し、従来のベアメタル製ステントからの移行が進んでいます。しかし、ステント治療には高額な費用がかかるため、低所得地域ではステント治療へのアクセスが制限される可能性があるほか、メーカーが通過しなければならない規制上のハードルも厳しいなど、市場は課題に直面しています。さらに、ステント血栓症や再狭窄といった潜在的な合併症は、患者や医療プロバイダーにとって依然として懸念事項であり、市場力学に影響を与えています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

冠動脈ステント市場規模：タイプ別&CAGR（2024～2031年）

• 市場概要
• ベアメタルステント
• 薬剤溶出ステント
• 生体吸収性ステント

冠動脈ステント市場規模：配達別&CAGR（2024～2031年）

• 市場概要
• バルーン拡大型ステント
• 自己拡大型ステント

冠動脈ステント市場規模：材料別&CAGR（2024～2031年）

• 市場概要
• 金属ステント
• コバルトクロム
• プラチナクロム
• ニッケルチタン
• ステンレス
• その他のステント

冠動脈ステント市場規模：エンドユーザー別&CAGR（2024～2031年）

• 市場概要
• 病院
• 心臓センター
• 外来手術センター

冠動脈ステント市場規模&CAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
• 製品ポートフォリオ分析
• セグメント別シェア分析
• 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Abbott Laboratories（米国）
• Medtronic plc（アイルランド）
• Boston Scientific Corporation（米国）
• Biosensors International Group, Ltd.（シンガポール）
• BIoTronik SE & Co. KG（ドイツ）
• B. Braun Melsungen AG（ドイツ）
• Terumo Corporation（日本）
• MicroPort Scientific Corporation（中国）
• Lepu Medical Technology（Beijing）Co., Ltd.（中国）
• Sahajanand Medical Technologies Pvt. Ltd.（インド）
• Meril Life Sciences Pvt. Ltd.（インド）
• Vascular Concepts（インド）
• Translumina GmbH（ドイツ）
• Cordis Corporation（米国）
• Reva Medical, Inc.（米国）
• Elixir Medical Corporation（米国）
• Stentys SA（フランス）
• Alvimedica（トルコ）
• Balton Medical（スウェーデン）
• Cardionovum（米国）

結論と推奨事項

Global Coronary Stent Market size was valued at USD 9.9 billion in 2022 and is poised to grow from USD 10.22 billion in 2023 to USD 13.14 billion by 2031, growing at a CAGR of 3.2% during the forecast period (2024-2031).

The global coronary stent market is experiencing notable growth, driven by a surge in cardiovascular diseases, an aging population, and increasing preference for minimally invasive procedures. As lifestyle changes and unhealthy diets contribute to the rising incidence of these conditions, the demand for coronary stents is heightened. Technological innovations, such as drug-eluting and bioresorbable stents, have enhanced patient outcomes and safety, promoting a transition from traditional bare-metal options. However, the market faces challenges, including the high costs of stent procedures, which may restrict access in lower-income regions, along with stringent regulatory hurdles that manufacturers must navigate. Additionally, potential complications like stent thrombosis and restenosis remain concerns for patients and healthcare providers alike, affecting market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coronary Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Stent Market Segmental Analysis

Global Coronary Stent Market is segmented by type, delivery, material, end user and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. Based on delivery, the market is segmented into balloon-expandable stents and self-expanding stents. Based on material, the market is segmented into metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel and other stents. Based on end user, the market is segmented into hospitals, cardiac centers and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coronary Stent Market

The global coronary stent market is significantly driven by the escalating prevalence of cardiovascular diseases, particularly coronary artery disease. Factors such as unhealthy dietary habits, sedentary lifestyles, and other lifestyle modifications have contributed to an alarming rise in these health conditions worldwide. As more individuals are diagnosed with cardiovascular ailments, the demand for effective treatments, including coronary stents, continues to increase. This growing health crisis emphasizes the need for innovative medical solutions, making coronary stents an essential component in the management and treatment of heart-related diseases, thus propelling the market forward.

Restraints in the Global Coronary Stent Market

The Global Coronary Stent market faces significant constraints due to stringent regulatory approval processes instituted by governing bodies. These rigorous requirements necessitate comprehensive safety and efficacy evaluations, which can be both time-consuming and resource-draining for manufacturers. Consequently, these lengthy approval timelines can hinder the timely introduction of innovative products into the market, stalling overall market growth and limiting competitiveness. As companies navigate the complexities of compliance, the potential for delays in product launches becomes a notable barrier, impacting their ability to respond swiftly to evolving market demands and capitalize on emerging opportunities.

Market Trends of the Global Coronary Stent Market

The global coronary stent market is witnessing a significant trend towards minimally invasive procedures, particularly percutaneous coronary intervention (PCI). This shift is fueled by an increasing patient preference for treatments that promise shorter hospital stays, faster recovery times, and reduced risks of complications compared to conventional open-heart surgeries. As healthcare professionals and patients alike recognize the advantages of these less invasive techniques, the demand for advanced coronary stents is surging. Furthermore, technological advancements in stent design and materials are enhancing efficacy and safety, solidifying their role in contemporary cardiovascular care and ensuring robust market growth in the upcoming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Coronary Stent Market Size by Type & CAGR (2024-2031)

• Market Overview
• Bare-Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

Global Coronary Stent Market Size by Delivery & CAGR (2024-2031)

• Market Overview
• Balloon-Expandable Stents
• Self-Expanding Stents

Global Coronary Stent Market Size by Material & CAGR (2024-2031)

• Market Overview
• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Other Stents

Global Coronary Stent Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Global Coronary Stent Market Size & CAGR (2024-2031)

• North America (Type, Delivery, Material, End User)
  • US
  • Canada
• Europe (Type, Delivery, Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group, Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Concepts (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Translumina GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stentys SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Medical (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations